The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Renal Biomarkers-Global Market Insights and Sales Trends 2025
Synopsis
Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.
The global Renal Biomarkers market size is expected to reach US$ 1643.2 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Renal Biomarkers in various end use industries. The expanding demands from the Diagnosis and Disease Progression Monitoring, Research and Others,, are propelling Renal Biomarkers market. Enzyme Linked Immunosorbent Assay (ELISA), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enzymatic Assay segment is estimated at % CAGR for the next seven-year period.
The major factors fuelling the global renal biomarkers market are increased incidence of kidney diseases, large geriatric population and increasing prevalence of multiple co-morbidities.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Renal Biomarkers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Renal Biomarkers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Renal Biomarkers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Renal Biomarkers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Renal Biomarkers covered in this report include Abbott Diagnostics, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Astute Medical, BioMerieux SA, Randox Laboratories and Diagnostics A/S, etc.
The global Renal Biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthcare Diagnostics
Thermo Fisher Scientific
Astute Medical
BioMerieux SA
Randox Laboratories
Diagnostics A/S
Sphingo Tec GmbH
Eli Lilly and Company
Novartis AG
Gentian Diagnostic
Proteomics International
BioPorto
Global Renal Biomarkers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Renal Biomarkers market, Segment by Type:
Enzyme Linked Immunosorbent Assay (ELISA)
Enzymatic Assay
Turbidimetric Immunoassay
Others
Global Renal Biomarkers market, by Application
Diagnosis and Disease Progression Monitoring
Research
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Renal Biomarkers companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.
The global Renal Biomarkers market size is expected to reach US$ 1643.2 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Renal Biomarkers in various end use industries. The expanding demands from the Diagnosis and Disease Progression Monitoring, Research and Others,, are propelling Renal Biomarkers market. Enzyme Linked Immunosorbent Assay (ELISA), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enzymatic Assay segment is estimated at % CAGR for the next seven-year period.
The major factors fuelling the global renal biomarkers market are increased incidence of kidney diseases, large geriatric population and increasing prevalence of multiple co-morbidities.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Renal Biomarkers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Renal Biomarkers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Renal Biomarkers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Renal Biomarkers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Renal Biomarkers covered in this report include Abbott Diagnostics, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Astute Medical, BioMerieux SA, Randox Laboratories and Diagnostics A/S, etc.
The global Renal Biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthcare Diagnostics
Thermo Fisher Scientific
Astute Medical
BioMerieux SA
Randox Laboratories
Diagnostics A/S
Sphingo Tec GmbH
Eli Lilly and Company
Novartis AG
Gentian Diagnostic
Proteomics International
BioPorto
Global Renal Biomarkers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Renal Biomarkers market, Segment by Type:
Enzyme Linked Immunosorbent Assay (ELISA)
Enzymatic Assay
Turbidimetric Immunoassay
Others
Global Renal Biomarkers market, by Application
Diagnosis and Disease Progression Monitoring
Research
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Renal Biomarkers companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Renal Biomarkers
1.1 Renal Biomarkers Market Overview
1.1.1 Renal Biomarkers Product Scope
1.1.2 Renal Biomarkers Market Status and Outlook
1.2 Global Renal Biomarkers Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Renal Biomarkers Market Size by Region (2018-2029)
1.4 Global Renal Biomarkers Historic Market Size by Region (2018-2023)
1.5 Global Renal Biomarkers Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Renal Biomarkers Market Size (2018-2029)
1.6.1 North America Renal Biomarkers Market Size (2018-2029)
1.6.2 Europe Renal Biomarkers Market Size (2018-2029)
1.6.3 Asia-Pacific Renal Biomarkers Market Size (2018-2029)
1.6.4 Latin America Renal Biomarkers Market Size (2018-2029)
1.6.5 Middle East & Africa Renal Biomarkers Market Size (2018-2029)
2 Renal Biomarkers Market by Type
2.1 Introduction
2.1.1 Enzyme Linked Immunosorbent Assay (ELISA)
2.1.2 Enzymatic Assay
2.1.3 Turbidimetric Immunoassay
2.1.4 Others
2.2 Global Renal Biomarkers Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Renal Biomarkers Historic Market Size by Type (2018-2023)
2.2.2 Global Renal Biomarkers Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Renal Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Renal Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Renal Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Renal Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Renal Biomarkers Revenue Breakdown by Type (2018-2029)
3 Renal Biomarkers Market Overview by Application
3.1 Introduction
3.1.1 Diagnosis and Disease Progression Monitoring
3.1.2 Research
3.1.3 Others
3.2 Global Renal Biomarkers Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Renal Biomarkers Historic Market Size by Application (2018-2023)
3.2.2 Global Renal Biomarkers Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Renal Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Renal Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Renal Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Renal Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Renal Biomarkers Revenue Breakdown by Application (2018-2029)
4 Renal Biomarkers Competition Analysis by Players
4.1 Global Renal Biomarkers Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Renal Biomarkers as of 2022)
4.3 Date of Key Players Enter into Renal Biomarkers Market
4.4 Global Top Players Renal Biomarkers Headquarters and Area Served
4.5 Key Players Renal Biomarkers Product Solution and Service
4.6 Competitive Status
4.6.1 Renal Biomarkers Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Diagnostics
5.1.1 Abbott Diagnostics Profile
5.1.2 Abbott Diagnostics Main Business
5.1.3 Abbott Diagnostics Renal Biomarkers Products, Services and Solutions
5.1.4 Abbott Diagnostics Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Diagnostics Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Renal Biomarkers Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 Beckman Coulter
5.3.1 Beckman Coulter Profile
5.3.2 Beckman Coulter Main Business
5.3.3 Beckman Coulter Renal Biomarkers Products, Services and Solutions
5.3.4 Beckman Coulter Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.3.5 Siemens Healthcare Diagnostics Recent Developments
5.4 Siemens Healthcare Diagnostics
5.4.1 Siemens Healthcare Diagnostics Profile
5.4.2 Siemens Healthcare Diagnostics Main Business
5.4.3 Siemens Healthcare Diagnostics Renal Biomarkers Products, Services and Solutions
5.4.4 Siemens Healthcare Diagnostics Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.4.5 Siemens Healthcare Diagnostics Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific Renal Biomarkers Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 Astute Medical
5.6.1 Astute Medical Profile
5.6.2 Astute Medical Main Business
5.6.3 Astute Medical Renal Biomarkers Products, Services and Solutions
5.6.4 Astute Medical Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.6.5 Astute Medical Recent Developments
5.7 BioMerieux SA
5.7.1 BioMerieux SA Profile
5.7.2 BioMerieux SA Main Business
5.7.3 BioMerieux SA Renal Biomarkers Products, Services and Solutions
5.7.4 BioMerieux SA Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.7.5 BioMerieux SA Recent Developments
5.8 Randox Laboratories
5.8.1 Randox Laboratories Profile
5.8.2 Randox Laboratories Main Business
5.8.3 Randox Laboratories Renal Biomarkers Products, Services and Solutions
5.8.4 Randox Laboratories Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.8.5 Randox Laboratories Recent Developments
5.9 Diagnostics A/S
5.9.1 Diagnostics A/S Profile
5.9.2 Diagnostics A/S Main Business
5.9.3 Diagnostics A/S Renal Biomarkers Products, Services and Solutions
5.9.4 Diagnostics A/S Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.9.5 Diagnostics A/S Recent Developments
5.10 Sphingo Tec GmbH
5.10.1 Sphingo Tec GmbH Profile
5.10.2 Sphingo Tec GmbH Main Business
5.10.3 Sphingo Tec GmbH Renal Biomarkers Products, Services and Solutions
5.10.4 Sphingo Tec GmbH Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.10.5 Sphingo Tec GmbH Recent Developments
5.11 Eli Lilly and Company
5.11.1 Eli Lilly and Company Profile
5.11.2 Eli Lilly and Company Main Business
5.11.3 Eli Lilly and Company Renal Biomarkers Products, Services and Solutions
5.11.4 Eli Lilly and Company Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.11.5 Eli Lilly and Company Recent Developments
5.12 Novartis AG
5.12.1 Novartis AG Profile
5.12.2 Novartis AG Main Business
5.12.3 Novartis AG Renal Biomarkers Products, Services and Solutions
5.12.4 Novartis AG Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.12.5 Novartis AG Recent Developments
5.13 Gentian Diagnostic
5.13.1 Gentian Diagnostic Profile
5.13.2 Gentian Diagnostic Main Business
5.13.3 Gentian Diagnostic Renal Biomarkers Products, Services and Solutions
5.13.4 Gentian Diagnostic Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.13.5 Gentian Diagnostic Recent Developments
5.14 Proteomics International
5.14.1 Proteomics International Profile
5.14.2 Proteomics International Main Business
5.14.3 Proteomics International Renal Biomarkers Products, Services and Solutions
5.14.4 Proteomics International Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.14.5 Proteomics International Recent Developments
5.15 BioPorto
5.15.1 BioPorto Profile
5.15.2 BioPorto Main Business
5.15.3 BioPorto Renal Biomarkers Products, Services and Solutions
5.15.4 BioPorto Renal Biomarkers Revenue (US$ Million) & (2018-2023)
5.15.5 BioPorto Recent Developments
6 North America
6.1 North America Renal Biomarkers Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Renal Biomarkers Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Renal Biomarkers Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Renal Biomarkers Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Renal Biomarkers Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Renal Biomarkers Market Dynamics
11.1 Renal Biomarkers Industry Trends
11.2 Renal Biomarkers Market Drivers
11.3 Renal Biomarkers Market Challenges
11.4 Renal Biomarkers Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
